A synthetic peptide inhibitor for α-chemokines inhibits the growth of melanoma cell lines

Journal of Clinical Investigation

Volumn 99, Issue 11, 1997, Pages 2581-2587

  Hayashi, Shinichiro ^a   Kurdowska, Anna ^a   Cohen, Allen B ^a,b   Stevens, Michael D ^a   Fujisawa, Nobumitsu ^a   Miller, Edmund J ^a  

^a UNIVERSITY OF TEXAS AT TYLER   (United States)

^b Health Science Center   (United States)

Author keywords

Growth inhibitor; Growth substances; Interleukin 8; Melanoma; Neoplastic proteins

Indexed keywords

ANTILEUKINATE; CHEMOKINE; GROWTH INHIBITOR; INTERLEUKIN 8; MELANOMA GROWTH STIMULATORY ACTIVITY FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CELL VIABILITY; CYTOTOXICITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; MELANOMA CELL; PRIORITY JOURNAL; RECEPTOR BINDING; SEQUENCE HOMOLOGY;

EID: 0030912143     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119446     Document Type: Article

References (23)

1. Richmond, A., D.H. Lawson, D.W. Nixon, J.S. Stevens, and R.K. Chawla. 1983. Extraction of a melanoma growth-stimulatory activity from culture medium conditioned by the Hs0294 human melanoma cell line. Cancer Res. 43:2106-2112.
2. Richmond, A., D.H. Lawson, D.W. Nixon, and R.K. Chawla. 1985. Characterization of autostimulatory and transforming growth factors from human melanoma cells. Cancer Res. 45:6390-6394.
3. Richmond, A., and H.G. Thomas. 1986. Purification of melanoma growth stimulatory activity. J. Cell. Physiol. 129:375-384.
4. Lawson, D.H., H.G. Thomas, R.G. Roy, D.S. Gordon, R.K. Chawla, D.W. Nixon, and A. Richmond. 1987. Preparation of a monoclonal antibody to a melanoma growth-stimulatory activity released into serum-free culture medium by Hs0294 malignant melanoma cells. J. Cell. Biochem. 34:169-185.
5. Mintz, B., and W.K. Silvers. 1993. Transgenic mouse model of malignant skin melanoma. Proc. Natl. Acad. Sci. USA. 90:8817-8821.
6. Oppenheim, J.J., C.O. Zachariae, N. Mukaida, and K. Matsushima. 1991. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu. Rev. Immunol. 9:617-648.
7. Murphy, P.M., and H.L. Tiffany. 1991. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science (Wash. DC). 253: 1280-1283.
8. Holmes, W.E., J. Lee, W.J. Kuang, G.C. Rice, and W.I. Wood. 1991. Structure and functional expression of a human interleukin-8 receptor. Science (Wash. DC). 253:1278-1280.
9. Mueller, S.G., W.P. Schraw, and A. Richmond. 1994. Melanoma growth stimulatory activity enhances the phosphorylation of the class II interleukin-8 receptor in non-hematopoietic cells. J. Biol. Chem. 269:1973-1980.
10. Moser, B., L. Barella, S. Mattei, C. Schumacher, F. Boulay, M.P. Colombo, and M. Baggiolini. 1993. Expression of transcripts for two interleukin 8 receptors in human phagocytes, lymphocytes and melanoma cells. Biochem. J. 294:285-292.
11. Norgauer, J., B. Metzner, and I. Schraufstatter. 1996. Expression and growth-promoting function of the IL-8 receptor beta in human melanoma cells. J. Immunol. 156:1132-1137.
12. Hayashi, S., A. Kurdowska, E.J. Miller, M.E. Albright, B.E. Girten, and A.B. Cohen. Synthetic hexa-and heptapeptides which inhibit IL-8 from binding to and activating human blood neutrophils. J. Immunol. 154:814-824.
13. Bolton, A.E., and W.M. Hunter. 1973. The labeling of proteins to high specific radioactivities by conjugation to a 125-I-containing acylating agent: application to the radioimmunoassay. Biochem. J. 133:529-539.
14. Horuk, R., D.G. Yansura, D. Reilly, S. Spencer, J. Bourell, W. Henzel, G. Rice, and E. Unemori. 1993. Purification, receptor binding analysis, and biological characterization of human melanoma growth stimulating activity (MGSA). J. Biol. Chem. 268:541-546.
15. Ko, Y.-C., N. Mukaida, A. Panyutich, N.N. Voitenok, K. Matsushima, T. Kawai, and T. Kasahara. 1992. A sensitive enzyme-linked immunosorbent assay for human interleukin-8. J. Immunol. Methods. 149:227-235.
16. Richmond, A., D.H. Lawson, and D.W. Nixon. 1982. Release of an autostimulatory growth activity by human malignant melanoma cells. Cold Spring Harbor Conference. Cell Proliferation. 9:885-897.
17. Richmond, A., R. Fine, D. Murray, D.H. Lawson, and J.H. Priest. 1986. Growth factor and cytogenetic abnormalities in cultured nevi and malignant melanomas. J. Invest. Dermatol. 86:295-302.
18. Richmond, A., E. Balentien, H.G. Thomas, G. Flaggs, D.E. Barton, J. Spiess, R. Borkoni, U. Francke, and R. Derynck. 1988. Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to beta-thromboglobulin. EMBO J. 7:2025-2033.
19. Schadendorf, D., A. Moller, B. Algermissen, M. Worm. M. Sticherling, and B.M. Czarnetzki. 1993. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J. Immunol. 151:2667-2675.
20. Singh, R.K., M. Gutman, R. Radinsky, C.D. Bucana, and I.J. Fidler. 1994. Expression of interleukin 8 correlates with metastatic potential of human melanoma cells in nude mice. Cancer Res. 54:3242-3247.
21. Nanney, L.B., S.G. Mueller, R. Bueno, S.C. Peiper, and A. Richmond. 1995. Distributions of melanoma growth stimulatory activity of growth-regulated gene and the interleukin-8 receptor B in human wound repair. Am. J. Pathol. 147:1248-1260.
22. Venner, T.J., D.N. Sauder, C. Feliciani, and R.C. Mckenzie. 1995. Interleukin-8 and melanoma growth-stimulating activity are induced by ultraviolet B radiation in human keratinocyte cell lines. Exp. Dermatol. 4:138-145.
23. Hayashi, S., M. Stevens, E. Miller, A. Kurdowska, R. Strieter, A. Walz, and A. Cohen. 1995. Characterization of the binding of epithelial neutrophil activating peptide-78 (ENA78) to interleukin-8 receptors. FASEB J. 9:A247.